APOE and Alzheimer disease: The mechanisms underlying this sex-linked and partly intertwined age- and APOE ε4-dependent heterogeneity in AD susceptibility and severity are only beginning to unravel, calling for novel approaches to further elucidate molecular sex differences in AD risk and biomarker profiles.